Doyle John Brendan - Insider Non-Derivative Transactions at COGNITION THERAPEUTICS INC (CGTX) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 18, 2025, Doyle John Brendan's relationship to COGNITION THERAPEUTICS INC (CGTX) is Officer (Chief Financial Officer), and currently has 455,350 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other CGTX insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Doyle John Brendan - Insider Non-Derivative Transactions of CGTX Common Stock

Doyle John Brendan - Insider Non-Derivative Transactions at CGTX

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 19, 2025	F -- (Common Stock)	9360	1.5	445990
Dec 19, 2025	Acquisition -- (Common Stock)	30000	0	455350
Jul 30, 2025	F -- (Common Stock)	9360	0.67	425350
Jul 30, 2025	Acquisition -- (Common Stock)	30000	0	434710
May 2, 2025	F -- (Common Stock)	9692	0.45	404710
Feb 16, 2025	F -- (Common Stock)	1723	0.59	414402
Feb 5, 2025	Acquisition -- (Common Stock)	295000	0	416125
May 2, 2024	F -- (Common Stock)	8699	1.95	121125
Feb 16, 2024	Acquisition -- (Common Stock)	20000	0	129824
May 2, 2023	Acquisition -- (Common Stock)	109824	0	109824